Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non-Small Cell Lung Cancer
Conclusion: Intra-abdominal metastases confer a particularly poor prognosis
in stage IV NSCLC treated with systemic therapy and may identify patients in whom aggressive treatment beyond first
line therapy is not appropriate.
PMID: 30051671 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Cardiology | Grants | Heart | Liver | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Skin | Statistics | Urology & Nephrology